Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Neuronal Signaling >  Histamine Receptor Antagonists >  Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride

Basic information Safety Supplier Related

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Basic information

Product Name:
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
Synonyms:
  • Cyclizine dihydrochloride
  • Piperazine, 1-benzhydryl-4-methyl-, dihydrochloride
  • Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
  • 1-Diphenylmethyl-4-methylpiperazine dihydrochloride
  • Cyclizine 2HCl
  • Piperazine, 1-(diphenylmethyl)-4-methyl-, hydrochloride (1:2)
  • Cyclizine 2hydrochloride
  • Marzine hydrochloride
CAS:
5897-18-7
MF:
C18H24Cl2N2
MW:
339.30256
Mol File:
5897-18-7.mol
More
Less

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Chemical Properties

storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
Soluble in DMSO > 10 mM
form 
Powder
More
Less

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Usage And Synthesis

Uses

Cyclizine dihydrochloride, a piperazine-derivative, is a potent and selective histamine H1 receptor antagonist. Cyclizine dihydrochloride can be used for the research of nausea, vomiting, and dizziness[1][2][3].

Biological Activity

Cyclizine 2HCl is a piperazine derivative with Histamine H1 receptor antagonist activity.

in vitro

Cyclizine is a piperazine histamine H1 receptor antagonist and has anticholinergic and antiemetic properties. It increases lower esophageal sphincter tone and reduces the sensitivity of tortuous organs.

in vivo

Cyclizine is metabolized to its N-desmethyl derivative, Norcyclizine, which has little antihistamine (H1) activity compared to Cyclizine. After oral administration of Cyclizine, the effect will be produced within 30 minutes, and the maximum effect will be achieved within 1-2 hours, which can last for 4-6 hours. Cyclizine administered orally at a dose of 50 mg alone in healthy adult volunteers produced peak plasma concentrations of approximately 70 ng/mL two hours after dosing. The plasma elimination half-life is about 20 hours.

target

TargetValue
Histamine H1 receptor

IC 50

H1 Receptor

References

[1] Králová J, et, al. The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity. Int Immunopharmacol. 2009 Jul;9(7-8):990-5. DOI:10.1016/j.intimp.2009.04.005
[2] Church MK, et, al. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 1980 Aug;69(4):663-7. DOI:10.1111/j.1476-5381.1980.tb07919.x
[3] Leza JC, et, al. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol. 1991;22(2):293-6. DOI:10.1016/0306-3623(91)90451-b

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochlorideSupplier

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Guangzhou Tomums Life Science Co., Ltd.
Tel
020-31155029 18902330969
Email
sales@tomums.cn
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Email
sales@invivochem.cn
Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com
Absin Bioscience Inc.
Tel
021-38015121 18438616290
Email
lanwu@univ-bio.com
More
Less

Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride(5897-18-7)Related Product Information